MedTrace Logo

Bone Microcirculation After Extracorporeal Shock Wave Therapy

NCT02424084 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-02-24

No results posted yet for this study

Summary

In trauma surgery and hand surgery treatment strategies of none healing bone fractures aim at replacing pseudarthrosis by well vascularized bone and improving microcirculation. Although previous studies indicate that extracorporeal shock wave therapy (ESWT) can accelerate bone healing in case of non-union, only a few studies focused on the elucidation of its mechanisms of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of extracorporeal shock wave therapy on scaphoid bones and metacarpal and metatarsal in a human in-vivo setting for the first time.

Conditions

  • Intact Scaphoid Bone
  • Intact Metacarpal Bone
  • Fractured Scaphoid Bone
  • Fractured Metacarpal Bone

Interventions

DEVICE

Extracorporeal Shock Wave Therapy (Device Name: PiezoWave)

Extracorporeal Shock Wave Therapy

Sponsors & Collaborators

  • University Hospital Schleswig-Holstein

    lead OTHER

Principal Investigators

  • Tobias Kisch, MD · University Hospital Schleswig-Holstein

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02424084 on ClinicalTrials.gov